NCT00345800View on ClinicalTrials.gov

Exploratory Clinical Study to Evaluate Sodium Oxybate (Xyrem) on Potential Endocrine Changes

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

April 10, 2006

Primary Completion Date

January 22, 2008

Study Completion Date

January 22, 2008

Conditions
Narcolepsy With Cataplexy
Interventions
DRUG

Sodium Oxybate (Xyrem)

"* Active Substance: Sodium Oxybate~* Pharmaceutical form: Oral Solution~* Concentration: 500 mg/mL oral solution from 4.5 to 9 g/day divided into two equal doses during 12 weeks~* Route of administration: Oral"

Trial Locations (1)

Unknown

Liège

All Listed Sponsors
lead

UCB Pharma SA

INDUSTRY

NCT00345800 - Exploratory Clinical Study to Evaluate Sodium Oxybate (Xyrem) on Potential Endocrine Changes | Biotech Hunter | Biotech Hunter